Enhancing CLIA Act of 2026 Enhancing Clinical Laboratory Innovation...
To amend the Public Health Services Act, commonly referred to as the "Clinical Laboratory Improvement Amendments" or "CLIA", with respect to laboratory developed tests, and for other purposes.
This bill, HB8890, aims to update the Clinical Laboratory Improvement Amendments (CLIA) by focusing on laboratory developed tests. It seeks to improve innovation and access to clinical lab services, ensuring they meet high standards of safety and effectiveness.
The changes would primarily affect clinical laboratories, healthcare providers, and patients who rely on lab tests for diagnosis and treatment. By improving the regulatory framework, it could lead to more reliable and accessible lab testing services, benefiting patients and healthcare providers alike.
HB8890 was introduced on May 19, 2026, and was referred to the Committee on Energy and Commerce and the Committee on Ways and Means for further consideration. As of now, it is in the early stages of the legislative process, and no further actions have been recorded.
